PSMA PET Imaging Market
PSMA PET Imaging Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
PSMA PET Imaging Market Size and Growth
The PSMA PET imaging market is experiencing significant growth, driven by increasing prostate cancer prevalence and technological advancements. The market size is projected to reach approximately $1.5 billion by 2025, with rising demand for precise diagnostics and targeted therapies enhancing its expansion amid evolving healthcare conditions and improved patient outcomes. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Fisher Scientific
◍ Aytu BioScience
◍ Abzena PLC
◍ Agilent Technologie
◍ Endocyte
◍ Bio Rad Laboratories
◍ Diagnostic BioSystems
◍ Blue Earth Diagnostics
◍ Bayer Health
◍ Seattle Genetics
The PSMA PET imaging market features companies like Blue Earth Diagnostics and Bayer Health focusing on radiopharmaceuticals for prostate cancer. Agilent Technologies and Bio Rad Laboratories enhance diagnostic capabilities. These firms contribute through innovative product development, clinical trials, and strategic partnerships, driving market growth through improved detection and treatment options.
- Blue Earth Diagnostics: ~$99 million in revenue.
- Bayer Health: Over €46 billion globally.
- Aytu BioScience: ~$17 million reported.
- Agilent Technologies: Approximately $5.7 billion.
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Diagnostic Centers
◍ Academic ReseaSch Institutions
By Product
◍ Less Than 55 Years of Age
Aged Between 55 and 75
Above 75 Years of Age
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
